PRESS

Mavatar Press

About Mavatar

Mavatar is a global specialist in AI-driven precision medicine solutions.

We combine advanced AI with deep biological insights to transform how diseases are understood, diagnosed, and treated—across all therapeutic areas.

Our Vision

We envision a future where everyone receives personalized, predictive, and effective care—tailored to their unique biology and needs.

Our Brand Promise

Decoding disease. Delivering precision.
We harness 20+ years of scientific research to make precision medicine a reality—at scale.

Who We Are

Mavatar delivers AI-powered precision medicine for both research and clinical care. Our proprietary DINA (Deep Integrated Network Analysis) framework drives two powerful platforms:

Mavatar Discovery – Accelerates disease research and drug development

Mavatar Precision – Provides personalized treatment recommendations through patient-specific digital twins

By simulating how individuals respond to different treatments, we enable better care decisions, reduce healthcare waste, and improve patient outcomes.

Global Impact & Collaborations

Headquartered in Sweden, Mavatar partners with leading pharmaceutical companies, universities, and hospital systems.

Together, we:

• Support biobank studies and clinical trials

• Identify novel drug targets and mechanisms of action

• Match patients to the best treatment options in real time

• Enable smarter drug repurposing and trial design

Mavatar is building the future of truly personalized, data-driven healthcare.

Boilerplate:

Mavatar is a global specialist in AI-driven precision medicine solutions for all diseases. Built on over 20 years of scientific research, Mavatar’s proprietary DINA (Deep Integrated Network Analysis) framework powers two flagship platforms: Mavatar Discovery for accelerating disease and drug research, and Mavatar Precision for delivering personalized treatment recommendations in clinical care. By creating digital twins of both patients and diseases, Mavatar enables data-driven decisions that improve treatment outcomes, optimize clinical trials, and reduce healthcare waste. Headquartered [insert location], Mavatar is driving the future of truly personalized, scalable healthcare across all disease areas. We envision a future where everyone receives personalized, predictive and effective care—powered by Mavatar.

The Company has partnerships with leading pharmaceutical companies, universities, and hospital systems. These collaborations focus on biobank studies and clinical trials, enabling research scientists to select the best drug candidates, suggest new uses for existing drugs, uncover new therapeutic targets, refine mechanisms of action, and match patients to innovative treatment options through point-of-care decision tools.